Aspen Pharmacare Mergers and Acquisitions Summary

Life ScienceCompany

Aspen Pharmacare has acquired 4 companies. It has also divested 2 assets.

Aspen Pharmacare’s largest acquisition to date was in 2013, when it acquired GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands for $1.1B. It’s largest disclosed sale occurred in 2020, when it sold Aspen Pharmacare Holdings - Thrombosis Business to Viatris for $723M. Aspen Pharmacare has acquired in 3 countries. The Company’s most targeted sectors include life science (75%) and food (25%).

Join Mergr and gain access to Aspen Pharmacare’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity6
    • M&A Buy Activity4
    • M&A Sell Activity2
  • Total Sectors Invested 2
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 4

Aspen Pharmacare

Aspen Pharmacare Holdings Ltd.

Aspen Place 9 Rydall Vale Park,
Durban, 4019
South Africa,
+27 31 580 8600
www.aspenpharma.com

Aspen Pharmacare is a global player in specialty, branded and generic pharmaceuticals, Aspen has an extensive basket of products that provide treatment for a broad spectrum of acute and chronic conditions experienced through all stages of life. The Group continues to increase the number of lives benefitting from its products, reaching more than 150 countries. In line with the Group’s commercial, production and territorial strategies, Aspen has identified thrombosis, anaesthetics, high potency & cytotoxics and infant nutritionals as four therapeutic categories which will get the highest focus based on materiality and future potential. Aspen Pharmacare was founded in 1850 and is based in Durban, South Africa.


M&A Summary

Buy vs Sell

Year ≤ '18 '19 '20 '21 '22 '23 T
Buy (0.0/yr) # 4 - - - - - 4
vol $2.0B $2.0B
Sell (0.4/yr) # - - 1 - 1 - 2
vol $723M $118M $842M
  6

Most Recent M&A

Company Date Value Type
Aspen Pharmacare Holdings - Prescription Medicines 2022-03-01 118M EUR Divestiture
Durban, South Africa
Aspen Pharmacare Holdings Ltd. - Thrombosis Business 2020-09-08 723M EUR Divestiture
, United Kingdom
New Zealand New Milk Ltd. 2014-10-31 - Stake Purchase
Auckland, New Zealand · www.newmilk.co.nz
GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands 2013-09-30 1.1B GBP Divestiture
, United Kingdom
GlaxoSmithKline - 25 Pharmaceutical Products 2012-08-15 265M GBP Divestiture
, Australia
Sigma Pharmaceuticals Ltd - Pharmaceutical Business 2010-08-16 640M AUD Divestiture
, Australia
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Aspen Global, Inc.    - Aspen Global, Inc. - Japanese Operations 2019-11-11 2
Grand Bay, Mauritius , Japan
Aspen Global, Inc.    - OTC Products 2014-02-28 1
Grand Bay, Mauritius Grand Bay, Mauritius
Aspen Global, Inc.    - GSK's Arixtra, Fraxiparine brands 2013-09-30 1
Grand Bay, Mauritius , United Kingdom

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 3 (75%) 2.0B (100%) 1 (50%) 723M (86%)
Food 1 (25%) - - -
Medical Products - - 1 (50%) 118M (14%)
Total 4 $2.0B 2 $842M

By Geo

State/Country Buy Value Sell Value
Australia 2 905M - -
United Kingdom 1 1.1B 1 723M
New Zealand 1 - - -
South Africa - - 1 118M
Domestic - - 1 (50%) 118M (14%)
Cross-border 4 (100%) 2.0B (100%) 1 (50%) 723M (86%)
Total 4 $2.0B 2 $842M

Deal Values

buy # Total
> $1B 1 $1.1B
$100M to $1B 2 $905M
TOTAL $2.0B
Largest GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands
$1.1B (2013-09-30)
sell # Total
$100M to $1B 2 $842M
TOTAL $842M
Largest Aspen Pharmacare Holdings Ltd. - Thrombosis Business
$723M (2020-09-08)

M&A Connections

Deals
Acquired from
Strategic(s)
75%
3 (75%)
Divested to
Strategic(s)
100%
2 (100%)

Company Summary

SECTOR

Life Science

Revenue

38,606   3% 2022
37,766   3% 2021
38,647   1% 2020
38,872   9% 2019
42,596   2018
(millions of ZAR) Show More Show Less

Employees

8,580

Established

1850

Public

JSE Limited: APN

 Subscribe to unlock this and 189,108
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.4K Private Equity Firms
  • 180K M&A Transactions
  • 185K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.5K M&A Advisors
    (Investment Banks and Law Firms)
  • 68K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Aspen Pharmacare

Life Science Companies , South Africa Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for South Africa Companies

Largest South Africa Companies , Acquisitive South Africa Companies , Recently Acquired South Africa Companies , Recently Sold South Africa Companies , Private South Africa Companies , Public South Africa Companies , Acquired South Africa Companies , PE Backed South Africa Companies
Mergr

Product

Company

Legal